报价延迟最少15分钟:2026/04/04 13:09 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.16 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.32/-0.29
|
|
企业价值
183.23M
|
| 资产负债 |
|
每股账面净值
1.28
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
40.52M
|
|
每股收益
0.73
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification. |
